New diabetes pill shows Real-World blood sugar benefits
NCT ID NCT04862923
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tracked 336 adults with type 2 diabetes in the UK who were already prescribed oral semaglutide (Rybelsus). The goal was to see how well the pill lowers blood sugar and affects body weight in everyday use. Participants took the medication as directed by their doctor and filled out questionnaires during regular visits over 8-10 months. The results help doctors understand how this once-daily pill works outside of a controlled research setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Master Centre for United Kingdom
Gatwick, West Sussex, RH6 0PA, United Kingdom
Conditions
Explore the condition pages connected to this study.